Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of ABCC1 in tumor cells has been implicated in the multidrug-resistant phenotype caused by cytotoxic drugs (60).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“ABCC1, which was originally cloned from the human small cell lung cancer cell line H69AR (60), is known to transport a variety of endogenous substrates, such as the antioxidant glutathione and pro-inflammatory leukotrienes (65).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“To date, at least 15 human ABC superfamily transporters, including ABCB1 (59), ABCC1 (60), and ABCG2 (61), have been reported to mediate multidrug resistance in different circumstances, including G12Ci treatment (27, 62, 63).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Progressive sequence alignment as a prerequisitetto correct phylogenetic trees
Feng, D.-F., & Doolittle, R. F. (1987) · Journal of Molecular Evolution · doi:10.1007/bf02603120 · Cited by 1,883
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Research works printed but not linked: 3
- GERLACH, J.H., MULTIDRUG RESISTANCE, CANCER SURVEYS 5: 25 (1986).
- UEYAMA, H, STRUCTURE OF A HUMAN SMOOTH-MUSCLE ACTIN GENE (AORTIC TYPE) WITH A UNIQUE INTRON SITE, MOLECULAR AND CELLULAR BIOLOGY 4: 1073 (1984).
- VANDERBLIEK, A.M., OVEREXPRESSION AND AMPLIFICATION OF 5 GENES IN A MULTIDRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE, MOLECULAR AND CELLULAR BIOLOGY 6: 1671 (1986).
Cited by
Items 201–300 of 1,012
Metal complexes as diagnostic tools
Reichert, D. E., Lewis, J. S., & Anderson, C. J. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(98)00207-0 · Cited by 263
Brangi, M., Litman, T., Ciotti, M., Nishiyama, K., Kohlhagen, G., Takimoto, C. H. M., Robey, R. W., Pommier, Y. G., Fojo, T., & Bates, S. E. (1999) · PubMed · Cited by 293
Arsenic Transport by the Human Multidrug Resistance Protein 1 (MRP1/ABCC1)
Leslie, E. M., Haimeur, A., & Waalkes, M. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404912200 · Cited by 261
Evers, R., Zaman, G. J., van Deemter, L., Jansen, H., Calafat, J., Oomen, L. C., Oude Elferink, R. P., Borst, P., & Schinkel, A. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118535 · Cited by 260
Multidrug resistance: Physiological principles and nanomedical solutions
Kunjachan, S., Rychlik, B., Storm, G., Kiessling, F., & Lammers, T. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.018 · Cited by 259
“In 1990, for instance, a 95 kDa membrane protein responsible for anthracycline resistance in MCF-7/AdrVp(100) cells was described [5], which later became known as BCRP (Breast Cancer Resistance Protein), and in 1992, Cole and coworkers identified and cloned another phosphoglycoprotein which was highly overexpressed in…”
BackgroundDrug resistance: Still a daunting challenge to the successful treatment of AML
Shaffer, B. C., Gillet, J.-P., Patel, C., Baer, M. R., Bates, S. E., & Gottesman, M. M. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.02.001 · Cited by 259
“The Expression and Role of ABC transporters in AML ABCB1/MDR1 (Juliano and Ling, 1976; Ueda et al., 1987), ABCC1/MRP1 (Cole et al., 1992), and ABCG2/BCRP (Doyle et al., 1998) are the most extensively studied genes in the ABC family, which includes 48 members divided into seven sub-families based on sequence similariti…”
Wu, C., Calcagno, A. M., & Ambudkar, S. V. (2008) · Current Molecular Pharmacology · doi:10.2174/1874-470210801020093 · Cited by 259
“ABCC1 [15] and ABCG2 [23] are more recently identified ABC drug transporters.”
BackgroundCharacterization of Drug Transport by the Human Multidrug Resistance Protein 3 (ABCC3)
Zelcer, N., Saeki, T., Reid, G., Beijnen, J. H., & Borst, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107041200 · Cited by 258
L??tsch, J., Skarke, C., Liefhold, J., & Geisslinger, G. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443140-00003 · Cited by 256
Renes, J., De Vries, E. G. E., Nienhuis, E. F., Jansen, P. L. M., & Müller, M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702360 · Cited by 256
“MRP1 was first identified in tumour cells with a multidrug resistant phenotype without overexpression of MDR1.(2) Although MRP1 is able to confer resistance to drugs which are MDR1 substrates, the substrate specificity of MRP1 seems different from that of MDR1.”
BackgroundWada, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.203 · Cited by 257
“The multidrug resistanceassociated protein (MRP) can also transport glutathione conjugates [leucotriene C4 (LTC4) and dinitrophenyl glutathione (GS-DNP)] (8,9), which are also putative substrates for transport by cMOAT protein, but the expression of the MRP gene in liver is very low ( 9).”
BackgroundDuffy, C. P., Elliott, C. J., O’Connor, R. A., Heenan, M. M., Coyle, S., Cleary, I. M., Kavanagh, K., Verhaegen, S., O’Loughlin, C. M., NicAmhlaoibh, R., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00045-8 · Cited by 253
SCHAUB, T. P., KARTENBECK, J., KÖNIG, J., SPRING, H., DÖRSAM, J., STAEHLER, G., STÖRKEL, S., THON, W. F., & KEPPLER, D. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061159 · Cited by 256
MDR- and CYP3A4-mediated drug–herbal interactions
Pal, D., & Mitra, A. K. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.010 · Cited by 254
Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges
Shukla, S., Wu, C.-P., & Ambudkar, S. V. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.2.205 · Cited by 253
“Soon after the discovery of MRP1 in 1992 [11] , the hunt for modulators of this ABC transporter became the research topic of interest.”
BackgroundJasinski, M., Ducos, E., Martinoia, E., & Boutry, M. (2003) · Plant Physiology · doi:10.1104/pp.102.014720 · Cited by 253
Theodoulou, F. L. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00132-2 · Cited by 250
Filella, M., Belzile, N., & Lett, M.-C. (2007) · Earth-Science Reviews · doi:10.1016/j.earscirev.2006.09.003 · Cited by 249
Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines
Kickhoefer, V. A., Rajavel, K. S., Scheffer, G. L., Dalton, W. S., Scheper, R. J., & Rome, L. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8971 · Cited by 248
Ballatori, N., Hammond, C. L., Cunningham, J. B., Krance, S. M., & Marchan, R. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.09.008 · Cited by 247
The Multifaceted Role of Glutathione S-Transferases in Health and Disease
Mazari, A. M. A., Zhang, L., Ye, Z.-W., Zhang, J., Tew, K. D., & Townsend, D. M. (2023) · Biomolecules · doi:10.3390/biom13040688 · Cited by 245
“In addition to GSTP1-1 inhibition, TLK199 has been shown to effectively inhibit multidrug resistance-associated protein 1 MRP1 (encoded by ABCC1 gene), which plays an essential role in multidrug resistance by its ability to effectively export an array of chemotherapeutic and other drugs out of the cell [100].”
BackgroundMembrane topology distinguishes a subfamily of the ATP‐binding cassette (ABC) transporters
Tusnády, G. E., Bakos, É., Váradi, A., & Sarkadi, B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01478-0 · Cited by 244
Evolution of ATP-binding cassette transporter genes
Dean, M. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80011-s · Cited by 245
Schneider, E., Horton, J. K., Yang, J. C., Nakagawa, M., & Cowan, K. H. (1994) · PubMed · Cited by 244
Frank, N. Y., Pendse, S. S., Lapchak, P. H., Margaryan, A., Shlain, D., Doeing, C., Sayegh, M. H., & Frank, M. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308700200 · Cited by 242
Di Pietro, A., Conseil, G., Pérez-Victoria, J. M., Dayan, G., Baubichon-Cortay, H., Trompier, D., Steinfels, E., Jault, J.-M., de Wet, H., Maitrejean, M., et al. (2002) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-002-8424-8 · Cited by 241
The Leishmania ATP-binding Cassette Protein PGPA Is an Intracellular Metal-Thiol Transporter ATPase
Légaré, D., Richard, D., Mukhopadhyay, R., Stierhof, Y.-D., Rosen, B. P., Haimeur, A., Papadopoulou, B., & Ouellette, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102351200 · Cited by 242
Wang, J.-Q., Yang, Y., Cai, C.-Y., Teng, Q.-X., Cui, Q., Lin, J., Assaraf, Y. G., & Chen, Z.-S. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100743 · Cited by 241
Glutathione and related enzymes in multidrug resistance
O'Brien, M. L., & Tew, K. D. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00051-2 · Cited by 241
Multidrug resistance mediated by the multidrug resistance protein (MRP) gene
Lautier, D., Canitrot, Y., Deeley, R. G., & Cole, S. P. C. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00450-9 · Cited by 239
Self-citationMechanisms of action of flavopiridol
Sedlacek, H. H. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00124-4 · Cited by 239
“[281] Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE,”
Backgroundvan Veen, H. W., Callaghan, R., Soceneantu, L., Sardini, A., Konings, W. N., & Higgins, C. F. (1998) · Nature · doi:10.1038/34669 · Cited by 239
“or the multidrug-resistance-associated protein MRP”
The Mucosa of the Small Intestine: How Clinically Relevant as an Organ of Drug Metabolism?
Doherty, M. M., & Charman, W. N. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241040-00001 · Cited by 239
List, A., Spier, C., Grogan, T., Johnson, C., Roe, D., Greer, J., Wolff, S., Broxterman, H., Scheffer, G., Scheper, R., et al. (1996) · Blood · doi:10.1182/blood.v87.6.2464.bloodjournal8762464 · Cited by 238
Zhang, Y., Han, H., Elmquist, W. F., & Miller, D. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02628-7 · Cited by 236
The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis
Assaraf, Y. G. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.09.001 · Cited by 235
Transport of amphipathic anions by human multidrug resistance protein 3.
Zeng, H., Liu, G., Rea, P. A., & Kruh, G. D. (2000) · PubMed · Cited by 255
The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
Wu, C.-P., Hsieh, C.-H., & Wu, Y.-S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200261n · Cited by 234
Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects
Ito, S., Ieiri, I., Tanabe, M., Suzuki, A., Higuchi, S., & Otsubo, K. (2001) · Pharmacogenetics · doi:10.1097/00008571-200103000-00008 · Cited by 234
Eisenblätter, T., Hüwel, S., & Galla, H.-J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02401-6 · Cited by 232
Improving Cancer Chemotherapy with Modulators of ABC Drug Transporters
Shukla, S., Ohnuma, S., & V. Ambudkar, S. (2011) · Current Drug Targets · doi:10.2174/138945011795378540 · Cited by 233
“MRP1 (ABCC1) was the first member of the MRP family to be identified (in 1992) and has been linked to the development of MDR (22).”
BackgroundABC Transporter-Mediated Multidrug-Resistant Cancer
Amawi, H., Sim, H.-M., Tiwari, A. K., Ambudkar, S. V., & Shukla, S. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-7647-4_12 · Cited by 228
Leslie, E. M., Mao, Q., Oleschuk, C. J., Deeley, R. G., & Cole, S. P. C. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1171 · Cited by 231
“In tumor cell lines, multidrug resistance is often associated with an ATP-dependent decrease in cellular drug accumulation attributed to the overexpression of one or other of the plasma membrane drug transporters: the 170-kDa P-glycoprotein (Juliano and Ling, 1976; Sharom, 1997) or the 190-kDa multidrug resistance pro…”
Self-citationMembrane transporters and channels in chemoresistance and -sensitivity of tumor cells
Huang, Y., & Sadée, W. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.07.032 · Cited by 230
Toh, S., Wada, M., Uchiumi, T., Inokuchi, A., Makino, Y., Horie, Y., Adachi, Y., Sakisaka, S., & Kuwano, M. (1999) · The American Journal of Human Genetics · doi:10.1086/302292 · Cited by 231
The role of ABC transporters in progression and clinical outcome of colorectal cancer
Hlavata, I., Mohelnikova-Duchonova, B., Vaclavikova, R., Liska, V., Pitule, P., Novak, P., Bruha, J., Vycital, O., Holubec, L., Treska, V., et al. (2012) · Mutagenesis · doi:10.1093/mutage/ger075 · Cited by 227
CFTR directly mediates nucleotide-regulated glutathione flux
Kogan, I. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg194 · Cited by 227
Self-citationMayer, R., Kartenbeck, J., Büchler, M., Jedlitschky, G., Leier, I., & Keppler, D. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.1.137 · Cited by 227
“c D N A (Cole et al., 1992) in two highly”
BackgroundInfluentialPharmacogenomics of ABC transporters and its role in cancer chemotherapy
Sparreboom, A., Danesi, R., Ando, Y., Chan, J., & Figg, W. D. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00005-0 · Cited by 226
“The ABCC1 gene was identified in the small cell lung carcinoma cell line NCI-H69, a multidrug-resistant cell that does not overexpress ABCB1 (Cole et al., 1992).”
BackgroundWang, R. B., Kuo, C. L., Lien, L. L., & Lien, E. J. (2003) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2003.00487.x · Cited by 225
Pluronics and MDR reversal: an update
Alakhova, D. Y., & Kabanov, A. V. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500298q · Cited by 224
The P-glycoprotein multidrug transporter
Fardel, O., Lecureur, V., & Guillouzo, A. (1996) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00081-x · Cited by 223
Xi, L. F., Koutsky, L. A., Galloway, D. A., Kiviat, N. B., Kuypers, J., Hughes, J. P., Wheeler, C. M., & Holmes, K. K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.796 · Cited by 223
“( 16 ) Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection.”
BackgroundInfluentialTransporters and Renal Drug Elimination
Lee, W., & Kim, R. B. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121856 · Cited by 222
Analysis of the MRP4 Drug Resistance Profile in Transfected NIH3T3 Cells
Lee, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1934 · Cited by 222
“The complementary DNA (cDNA) that encodes this 190-kd protein, multidrug resistanceassociated protein (MRP) 1, has been isolated from an anthracycline-resistant lung cancer cell line ( 3 ) and shown in transfection studies to have the capacity to confer a multidrug resistance phenotype (4,5).”
BackgroundMolecular Aspects of Renal Anionic Drug Transport
Russel, F. G. M., Masereeuw, R., & van Aubel, R. A. M. H. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.155913 · Cited by 221
Identifying chemogenetic interactions from CRISPR screens with drugZ
Colic, M., Wang, G., Zimmermann, M., Mascall, K., McLaughlin, M., Bertolet, L., Lenoir, W. F., Moffat, J., Angers, S., Durocher, D., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0665-3 · Cited by 219
“Drug transporter ABCC1 (encoding multi-drug resistance protein-1 , or MRP1), a known marker for clinical resistance to vincristine [45, 46], is the top synthetic hit in our screen (Fig.”
BackgroundYoung, L. C., Campling, B. G., Cole, S. P. C., Deeley, R. G., & Gerlach, J. H. (2001) · PubMed · Cited by 220
Self-citationDrug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood–brain barrier
Demeule, M., Régina, A., Jodoin, J., Laplante, A., Dagenais, C., Berthelet, F., Moghrabi, A., & Béliveau, R. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00201-x · Cited by 220
“MRP1, which was first described by Cole et al. (1992), was immunodetected by Western blots in human and rat choroid plexus but the presence of MRP1 in endothelial cells of brain capillaries remains controversial.”
BackgroundBroeks, A., Gerrard, B., Allikmets, R., Dean, M., & Plasterk, R. H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01001.x · Cited by 219
Mammalian multidrug-resistance proteins (MRPs)
Slot, A. J., Molinski, S. V., & Cole, S. P. C. (2011) · Essays in Biochemistry · doi:10.1042/bse0500179 · Cited by 218
Self-citationWemmie, J. A., Szczypka, M. S., Thiele, D. J., & Moye-Rowley, W. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31675-2 · Cited by 217
Transport Function and Hepatocellular Localization of mrp6 in Rat Liver
Madon, J., Hagenbuch, B., Landmann, L., Meier, P. J., & Stieger, B. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26431-2 · Cited by 218
“The latter does not contribute to the multidrug-resistant phenotype, and its overexpression has been found to be invariably associated with amplification of the MRP1 gene, which is localized adjacent to the MRP6 gene on human chromosome 16p13 (Kool et al., 1999a).”
InfluentialLeith, C., Chen, I., Kopecky, K., Appelbaum, F., Head, D., Godwin, J., Weick, J., & Willman, C. (1995) · Blood · doi:10.1182/blood.v86.6.2329.bloodjournal8662329 · Cited by 218
Dudley, M. E., Sundberg, J. P., & Roopenian, D. C. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960117)65:2<204::aid-ijc13>3.0.co;2-d · Cited by 18
Katzmann, D. J., Hallstrom, T. C., Voet, M., Wysock, W., Golin, J., Volckaert, G., & Moye-Rowley, W. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6875 · Cited by 216
“The two most closely related sequences were the mammalian multidrug resistanceassociated protein Mrp1p (10), with 33% identity, and yeast Ycf1p (45), with 32% identity.”
BackgroundInfluentialMembrane Topology of the Multidrug Resistance Protein (MRP)
Hipfner, D. R., Almquist, K. C., Leslie, E. M., Gerlach, J. H., Grant, C. E., Deeley, R. G., & Cole, S. P. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23623 · Cited by 216
Self-citationAnthracycline Antibiotics in Cancer Therapy: Focus on Drug Resistance
Booser, D. J., & Hortobagyi, G. N. (1994) · Drugs · doi:10.2165/00003495-199447020-00002 · Cited by 214
Doxorubicin gradients in human breast cancer.
Lankelma, J., Dekker, H., Luque, R. F., Luykx, S., Hoekman, K., van der Valk, P., van Diest, P. J., & Pinedo, H. M. (1999) · PubMed · Cited by 215
Human genetic diseases: a cross-talk between man and yeast
Foury, F. (1997) · Gene · doi:10.1016/s0378-1119(97)00140-6 · Cited by 215
The role of multidrug transporters in drug availability, metabolism and toxicity
Bodó, A., Bakos, É., Szeri, F., Váradi, A., & Sarkadi, B. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(02)00497-6 · Cited by 214
cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)1
Kiuchi, Y., Suzuki, H., Hirohashi, T., Tyson, C. A., & Sugiyama, Y. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00899-0 · Cited by 213
Molecular Pharmacology of ABCG2 and Its Role in Chemoresistance
Stacy, A. E., Jansson, P. J., & Richardson, D. R. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088609 · Cited by 210
“The gene encoding MRP1 (also known as ABCC1) was cloned by Cole et al in 1992, and similarly to Pgp, its overexpression conferred resistance to a range of chemotherapeutics (Cole et al., 1992).”
BackgroundRevisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
K. Tiwari, A., Sodani, K., Dai, C.-L., R. Ashby, C., & Chen, Z.-S. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795164048 · Cited by 211
Suzuki, H., & Sugiyama, Y. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00075-3 · Cited by 211
Membrane Topology and Glycosylation of the Human Multidrug Resistance-associated Protein
Bakos, É., Hegedüs, T., Holló, Z., Welker, E., Tusnády, G. E., Zaman, G. J. R., Flens, M. J., Váradi, A., & Sarkadi, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12322 · Cited by 211
Nakahira, S., Nakamori, S., Tsujie, M., Takahashi, Y., Okami, J., Yoshioka, S., Yamasaki, M., Marubashi, S., Takemasa, I., Miyamoto, A., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22390 · Cited by 209
“Variant cells with characteristics resistant to chemotherapeutic agents have widely contributed to the investigation of molecular mechanisms in chemoresistance.(7,12,13,16,18,19) These chemoresist-”
BackgroundThe Arabidopsis thaliana ABC transporter AtMRP5 controls root development and stomata movement
Gaedeke, N. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1875 · Cited by 210
The Roles of MRP2, MRP3, OATP1B1, and OATP1B3 in Conjugated Hyperbilirubinemia
Keppler, D. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055772 · Cited by 211
“1992 (Cole et al., 1992), human MRP2 was the second member of the MRP subfamily to be identified by molecular cloning and cellular localization in 1996 (reviewed by Nies and Keppler, 2007).”
BackgroundMethodHegedűs, T., Őrfi, L., Seprődi, A., Váradi, A., Sarkadi, B., & Kéri, G. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00095-9 · Cited by 207
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
Sajid, A., Rahman, H., & Ambudkar, S. V. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00612-3 · Cited by 201
“A second member of the ABC transporter family, ABCC1 (also known as MRP1), was discovered when tumour samples lacking overexpression of ABCB1 still exhibited resistance to many chemotherapeutic agents 14 .”
BackgroundVersantvoort, C., Broxterman, H., Bagrij, T., Scheper, R., & Twentyman, P. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.281 · Cited by 207
Ishikawa, T., Wright, C. D., & Ishizuka, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62016-8 · Cited by 206
Evers, R., Kool, M., Smith, A. J., Deemter, L. V., de Haas, M., & Borst, P. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1260 · Cited by 206
“In humans, two ABC transpor have been identified that can cause resistance in tumour MDR1 P-glycoprotein (Pgp) (Juliano and Ling, 1976), and multidrug resistance protein (MRP1) (Cole et al, 1992).”
BackgroundSzakács, G., Hall, M. D., Gottesman, M. M., Boumendjel, A., Kachadourian, R., Day, B. J., Baubichon-Cortay, H., & Di Pietro, A. (2014) · Chemical Reviews · doi:10.1021/cr4006236 · Cited by 203
Smital, T., Luckenbach, T., Sauerborn, R., Hamdoun, A. M., Vega, R. L., & Epel, D. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.06.006 · Cited by 204
The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
Januchowski, R., Wojtowicz, K., & Zabel, M. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.04.005 · Cited by 202
Legrand, O., Simonin, G., Perrot, J.-Y., Zittoun, R., & Marie, J.-P. (1998) · Blood · doi:10.1182/blood.v91.12.4480 · Cited by 204
Autophagy and doxorubicin resistance in cancer
Chen, C., Lu, L., Yan, S., Yi, H., Yao, H., Wu, D., He, G., Tao, X., & Deng, X. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000572 · Cited by 202
An ABCC-type transporter endowing glyphosate resistance in plants
Pan, L., Yu, Q., Wang, J., Han, H., Mao, L., Nyporko, A., Maguza, A., Fan, L., Bai, L., & Powles, S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100136118 · Cited by 196
“, HsABCC1 or HsMRP1) are PM located and are able to pump certain chemotherapeutic drugs and other xenobiotics out of cancer cells, thereby conferring resistance to anticancer drugs (30).”
BackgroundABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2
Kerb, R., Hoffmeyer, S., & Brinkmann, U. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.1.51 · Cited by 202
“The MRPs were discovered as a second type of drug pump in cancer cells exhibiting MDR not caused by MDR1 [2].”
BackgroundNovel mechanisms of drug resistance in leukemia
Ross, D. (2000) · Leukemia · doi:10.1038/sj.leu.2401694 · Cited by 202
Wijnholds, J., Scheffer, G. L., van der Valk, M., van der Valk, P., Beijnen, J. H., Scheper, R. J., & Borst, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.797 · Cited by 202
“In human cancer cells, MDR can be caused by the enhanced drug efflux mediated by two members of the ATP-binding cassette (ABC) superfamily of transporter proteins, the MDR gene 1 (MDR1) P-glycoprotein (Pgp; reference 1) and MDR protein 1 (MRP1 [2–6]).”
BackgroundMitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance
Giddings, E. L., Champagne, D. P., Wu, M.-H., Laffin, J. M., Thornton, T. M., Valenca-Pereira, F., Culp-Hill, R., Fortner, K. A., Romero, N., East, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23071-6 · Cited by 199
Zelcer, N., Huisman, M. T., Reid, G., Wielinga, P., Breedveld, P., Kuil, A., Knipscheer, P., Schellens, J. H. M., Schinkel, A. H., & Borst, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303504200 · Cited by 200
Allen, J. D., Brinkhuis, R. F., van Deemter, L., Wijnholds, J., & Schinkel, A. H. (2000) · PubMed · Cited by 236
ATP-binding cassette (ABC) transporters in normal and pathological lung
van der Deen, M., de Vries, E. G., Timens, W., Scheper, R. J., Timmer-Bosscha, H., & Postma, D. S. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-59 · Cited by 198
“Cole et al . discovered in 1992 a non-Pgp mediated MDR mechanism in the human lung cancer cell line H69AR [46].”
InfluentialMultidrug resistance and the role of P-glycoprotein knockout mice
Schinkel, A. H., Mol, C. A. A. M., Wagenaar, E., van Deemter, L., Smit, J. J. M., & Borst, P. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00130-b · Cited by 199
Analysis of the Drug Resistance Profile of Multidrug Resistance Protein 7 (ABCC10)
Hopper-Borge, E., Chen, Z.-S., Shchaveleva, I., Belinsky, M. G., & Kruh, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3111 · Cited by 198
Gefitinib reverses breast cancer resistance protein–mediated drug resistance
Yanase, K., Tsukahara, S., Asada, S., Ishikawa, E., Imai, Y., & Sugimoto, Y. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1119.3.9 · Cited by 196
“P-glycoprotein (1, 2) and MRP1 (3), are involved in multidrug resistance.”
BackgroundInfluential
Metadata
- Authors
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G.
- Affiliations
- Queen's University (CA)
- Venue
- Science
- Published
- 1992-12-04
- Volume
- 258
- Issue
- 5088
- Pages
- 1650-1654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2168070336
- Cited by
- 3,037
- References
- 47
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 46 · 2023: 55 · 2022: 40 · 2021: 53 · 2020: 61 · 2019: 39 · 2018: 45 · 2017: 55 · 2016: 66 · 2015: 67 · 2014: 79 · 2013: 80 · 2012: 77
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- multidrug resistance, lung cancer, doxorubicin resistance, ABC transporters, gene amplification, P-glycoprotein, mRNA overexpression, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Chromosome Banding, Chromosomes, Human, Pair 16, Doxorubicin, Drug Resistance, Gene Amplification, Multigene Family, Humans, Lung, Lung Neoplasms, Male, Membrane Glycoproteins, Molecular Sequence Data, Phylogeny, RNA, Messenger, Testis, Tumor Cells, Cultured, Sequence Homology, Amino Acid, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.